Annual Shareholders Equity
$15.13 M
-$163.65 M-91.54%
December 31, 2022
Summary
- As of February 10, 2025, RUBY annual stockholders equity is $15.13 million, with the most recent change of -$163.65 million (-91.54%) on December 31, 2022.
- During the last 3 years, RUBY annual shareholders equity has fallen by -$259.08 million (-94.48%).
Performance
RUBY Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$15.13 M
-$21.46 M-58.64%
December 31, 2022
Summary
- As of February 10, 2025, RUBY quarterly stockholders equity is $15.13 million, with the most recent change of -$21.46 million (-58.64%) on December 31, 2022.
- Over the past year, RUBY quarterly shareholders equity has dropped by -$163.65 million (-91.54%).
Performance
RUBY Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
RUBY Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -91.5% | -91.5% |
| 3 y3 years | -94.5% | -94.5% |
| 5 y5 years | +134.6% | +134.6% |
RUBY Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.5% | at low | -91.5% | at low |
| 5 y | 5-year | -94.5% | at low | -95.0% | at low |
| alltime | all time | -96.1% | -388.7% | -96.3% | -567.3% |
Rubius Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $15.13 M(-91.5%) | $15.13 M(-58.6%) |
| Sep 2022 | - | $36.59 M(-61.7%) |
| Jun 2022 | - | $95.54 M(-29.0%) |
| Mar 2022 | - | $134.65 M(-24.7%) |
| Dec 2021 | $178.78 M(+26.3%) | $178.78 M(-20.3%) |
| Sep 2021 | - | $224.21 M(-15.1%) |
| Jun 2021 | - | $264.11 M(-12.2%) |
| Mar 2021 | - | $300.98 M(+112.6%) |
| Dec 2020 | $141.56 M | $141.56 M(-18.2%) |
| Sep 2020 | - | $173.12 M(-15.7%) |
| Jun 2020 | - | $205.47 M(-12.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $235.16 M(-14.2%) |
| Dec 2019 | $274.21 M(-30.2%) | $274.21 M(-10.8%) |
| Sep 2019 | - | $307.34 M(-10.6%) |
| Jun 2019 | - | $343.64 M(-7.5%) |
| Mar 2019 | - | $371.64 M(-5.4%) |
| Dec 2018 | $393.01 M(-999.6%) | $393.01 M(-4.4%) |
| Sep 2018 | - | $411.01 M(-681.3%) |
| Jun 2018 | - | -$70.71 M(-138.0%) |
| Mar 2018 | - | $186.16 M(-526.1%) |
| Dec 2017 | -$43.69 M(+155.1%) | -$43.69 M |
| Dec 2016 | -$17.12 M | - |
FAQ
- What is Rubius Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Rubius Therapeutics?
- What is Rubius Therapeutics annual shareholders equity year-on-year change?
- What is Rubius Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Rubius Therapeutics?
- What is Rubius Therapeutics quarterly shareholders equity year-on-year change?
What is Rubius Therapeutics annual stockholders equity?
The current annual shareholders equity of RUBY is $15.13 M
What is the all time high annual shareholders equity for Rubius Therapeutics?
Rubius Therapeutics all-time high annual stockholders equity is $393.01 M
What is Rubius Therapeutics annual shareholders equity year-on-year change?
Over the past year, RUBY annual stockholders equity has changed by -$163.65 M (-91.54%)
What is Rubius Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of RUBY is $15.13 M
What is the all time high quarterly shareholders equity for Rubius Therapeutics?
Rubius Therapeutics all-time high quarterly stockholders equity is $411.01 M
What is Rubius Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, RUBY quarterly stockholders equity has changed by -$163.65 M (-91.54%)